intoDNA News

Check out news and press releases or download our publications.

intoDNA News

Check out news and press releases or download our publications.
May 18, 2023

intoDNA to exhibit at the BIO International Convention 2023

intoDNA will be exhibiting at the BIO International Convention 2023 in Boston, MA.
May 18, 2023

intoDNA to exhibit at the BIO International Convention 2023

Mar 28, 2023

intoDNA to present and exhibit at the American Association for Cancer Research Annual Meeting 2023

Jul 19, 2022

intoDNA joins the BioInMed initiative gathering key medical biotechnology companies in Poland

Apr 28, 2022

Magda Kordon as an invited speaker at the DNA Repair/Replication Structures & Cancer Conference

Mar 25, 2022

STRIDE Workshop at the PARP Meeting in Cold Spring Harbor Lab

Feb 24, 2022

Magda Kordon, CEO attending the 2022 Gordon Research Conference on DNA Damage, Mutation and Cancer

Jan 24, 2022

intoDNA to present at the 5th Annual DDR, ATR and PARP Inhibitors Summit

Dec 20, 2021

intoDNA awarded funding from the Polish Agency for Enterprise Development

Sep 28, 2021

STRIDE featured in Frontiers by our partners at Universitat Autònoma de Barcelona

Selected Publications

Development and validation of a novel sSTRIDE-MMR functional assay to study the efficiency of MMR inhibitors (AACR 2023)

Maja Białecka, Kamil Solarczyk, Karolina Uznańska, Olga Wójcikowska, et al.

Novel functional dSTRIDE-HR assays to report on the status of homologous recombination repair in cancer cells (AACR 2023)

Kamil Solarczyk, Agnieszka Waligórska, Karolina Uznańska, Zsombor Prucsi, et al.

Let’s not take DNA breaks for granted. The importance of direct detection of DNA breaks for the successful development of DDR inhibitors

Magdalena M Kordon and Kamil Solarczyk

Stay Updated

We are a fast-paced company, continually improving on our technology, processes and business frontiers.

We look forward to sharing more of our progress in the future.

Stay Updated

We are a fast-paced company, continually improving on our technology, processes and business frontiers.

We look forward to sharing more of our progress in the future.